SCHEMBL21044317

SCHEMBL21044317

COC(=O)C(OC)c1csc(N)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.42
MAPT P10636 6/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
NPC1 O15118 3/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
LMNA P02545 1/20 0.42
KDM4E B2RXH2 6/20 0.39
PKM P14618 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PIK3CG P48736 1/20 0.38
BACE1 P56817 1/20 0.37
HSD17B10 Q99714 4/20 0.37
GABRA5 P31644 1/20 0.37
GABRB2 P47870 1/20 0.37
TSHR P16473 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8871075 0.85 HSD17B10 (0.41) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL27785479 0.80 ALDH1A1 (0.36) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL22869101 0.76 ABL1 (0.39) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL4295655 0.75 SMN1; SMN2 (0.43) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL8336518 0.75 BACE1 (0.41) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL30885558 0.74 BACE1 (0.36) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL5415028 0.72 ALDH1A1 (0.43) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL4686595 0.72 MAPT (0.50) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL9355248 0.72 BACE1 (0.41) ALDH1A1MAPTMEN1KMT2ANPC1
SCHEMBL10753156 0.72 BACE1 (0.41) ALDH1A1MAPTMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3717459-B1 COMPOUNDS STEP PHARMA S A S (FR) 2026-01-21 EP disclosed
US-12503466-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2025-12-23 US disclosed
US-20240010645-A1 Aminothiazole Compounds as Inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2024-01-11 US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 US disclosed
US-20210002269-A1 COMPOUNDS STEP PHARMA S.A.S. (FR) 2021-01-07 US disclosed
US-20210002269-A1 COMPOUNDS STEP PHARMA S.A.S. (FR) 2021-01-07 US disclosed
EP-3717459-A1 COMPOUNDS Step Pharma S.A.S. (FR) 2020-10-07 EP disclosed
EP-3492454-A1 COMPOUNDS Step Pharma S.A.S. (FR) 2019-06-05 EP disclosed
EP-3492454-A1 COMPOUNDS Step Pharma S.A.S. (FR) 2019-06-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12503466-B2 Aminothiazole compounds as inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 ALDH1A1 3425/4885MAPT 2491/4885MEN1 4301/4885
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 ALDH1A1 3425/4885MAPT 2491/4885MEN1 4301/4885
US-20210002269-A1 COMPOUNDS UGT1A1, CYP1A1, CYP19A1 ALDH1A1 181/4885MAPT 2044/4885MEN1 192/4885
US-20240010645-A1 Aminothiazole Compounds as Inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 ALDH1A1 3425/4885MAPT 2491/4885MEN1 4301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.